GIVAREX Trademark

Trademark Overview

On Tuesday, January 3, 1995, a trademark application was filed for GIVAREX with the United States Patent and Trademark Office. The USPTO has given the GIVAREX trademark a serial number of 74617225. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Saturday, June 19, 2010. This trademark is owned by Biomira Research Inc.. The GIVAREX trademark is filed in the Pharmaceutical Products category with the following description:

gastrointestinal cancer vaccine based on a murine monoclonal antibody and a gastrointestinal cancer pharmaceutical preparations for vaccination consisting of the monoclonal antibody supplied in a proprietary formulation for intravenous, subcutaneous, intraperitoneal or intramuscular injection in humans

General Information

Serial Number74617225
Word MarkGIVAREX
Filing DateTuesday, January 3, 1995
Status710 - CANCELLED - SECTION 8
Status DateSaturday, June 19, 2010
Registration Number2782084
Registration DateTuesday, November 11, 2003
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 28, 2003

Trademark Statements

Goods and Servicesgastrointestinal cancer vaccine based on a murine monoclonal antibody and a gastrointestinal cancer pharmaceutical preparations for vaccination consisting of the monoclonal antibody supplied in a proprietary formulation for intravenous, subcutaneous, intraperitoneal or intramuscular injection in humans

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateSaturday, June 19, 2010
Primary Code005
First Use Anywhere DateWednesday, May 14, 2003
First Use In Commerce DateWednesday, May 14, 2003

Trademark Owner History

Party NameALTAREX MEDICAL CORP.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressEDMONTON, ALBERTA T6E 6S4
CA
Party NameALTAREX CORP.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressEDMONTON, ALBERTA T6G 2N8
CA
Party NameALTAREX CORP.
Party Type23 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressEDMONTON, ALBERTA T6G 2N8
CA
Party NameALTAREX INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressEDMONTON, ALBERTA
CA
Party NameBiomira Research Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEdmonton, Alberta T6G 2N8
CA
Party NameBiomira Research Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEdmonton, Alberta T6G 2N8
CA

Trademark Events

Event DateEvent Description
Saturday, June 19, 2010CANCELLED SEC. 8 (6-YR)
Tuesday, March 15, 2005ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 15, 2005TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 11, 2003REGISTERED-PRINCIPAL REGISTER
Thursday, August 21, 2003ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 21, 2003ASSIGNED TO EXAMINER
Tuesday, August 19, 2003CASE FILE IN TICRS
Saturday, August 9, 2003STATEMENT OF USE PROCESSING COMPLETE
Tuesday, July 22, 2003USE AMENDMENT FILED
Tuesday, July 22, 2003TEAS STATEMENT OF USE RECEIVED
Tuesday, April 22, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 28, 2003PUBLISHED FOR OPPOSITION
Wednesday, January 8, 2003NOTICE OF PUBLICATION
Monday, October 28, 2002SEC. 44(D) CLAIM DELETED
Monday, October 28, 2002PAPER RECEIVED
Friday, November 1, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 19, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 18, 2002LETTER OF SUSPENSION MAILED
Friday, September 13, 2002PETITION TO REVIVE-GRANTED
Monday, August 19, 2002COMMUNICATION RECEIVED FROM PETITIONER
Monday, August 19, 2002PAPER RECEIVED
Tuesday, July 23, 2002INCOMPLETE PETITION NOTICE MAILED
Thursday, March 7, 2002PETITION TO REVIVE-RECEIVED
Thursday, February 28, 2002ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, February 28, 2002ASSIGNED TO EXAMINER
Tuesday, March 13, 2001INQUIRY AS TO SUSPENSION MAILED
Monday, August 14, 2000CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 12, 2000LETTER OF SUSPENSION MAILED
Thursday, November 18, 1999CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 10, 2000INQUIRY AS TO SUSPENSION MAILED
Wednesday, July 14, 1999LETTER OF SUSPENSION MAILED
Tuesday, May 18, 1999INQUIRY AS TO SUSPENSION MAILED
Friday, November 13, 1998LETTER OF SUSPENSION MAILED
Tuesday, October 13, 1998CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 8, 1998LETTER OF SUSPENSION MAILED
Friday, March 13, 1998NON-FINAL ACTION MAILED
Friday, March 13, 1998ASSIGNED TO EXAMINER
Friday, October 3, 1997LETTER OF SUSPENSION MAILED
Friday, October 3, 1997ASSIGNED TO EXAMINER
Saturday, February 17, 1996INQUIRY AS TO SUSPENSION MAILED
Friday, August 11, 1995LETTER OF SUSPENSION MAILED
Tuesday, July 11, 1995CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 19, 1995NON-FINAL ACTION MAILED
Monday, May 8, 1995ASSIGNED TO EXAMINER

Related Keywords

givarex gastrointestinal antibody monoclonal cancer intravenous formulation subcutaneous intraperitoneal intramuscular proprietary